Key result
Cardio-neuromodulation through a right-sided, CT-guided approach reduced syncope burden by 95% at 6-month follow-up (P<0.001).
Why the study?
Does unifocal right-sided cardio-neuromodulation improve heart rate and reduce syncope burden in patients with neurally mediated syncope and functional sinus node dysfunction?
Cohort (n=20)
Does unifocal right-sided cardio-neuromodulation improve heart rate and reduce syncope burden in patients with neurally mediated syncope and functional sinus node dysfunction?
p-value: p=<0.001
CT-guided unifocal right-sided cardio-neuromodulation significantly reduces syncope burden and inappropriate bradycardia in patients with neurally mediated syncope and functional sinus node dysfunction.
No takes yet. Share an insight, caveat, or question.
May reduce syncope burden in this population; hypothesis-generating and requires randomized trials before practice change.
Debruyne et al. (2018) conducted a cohort in Neurally mediated syncope and functional sinus node dysfunction (n=20). Cardio-neuromodulation (unifocal right-sided ablation under CT guidance) was evaluated on Syncope burden reduction (p=<0.001). Cardio-neuromodulation through a right-sided, CT-guided approach reduced syncope burden by 95% at 6-month follow-up (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: